Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBMYBristol Myers SquibbGSKGSK plcPFEPfizer
Snapshot
Price$64.49$52.81$26.46
Market cap$118.71B$102.51B$138.61B
Valuation
P/E22.1x13.8x20.1x
Forward P/E17.5x9.8x21.2x
Growth
Revenue growth1.8%4.0%1.4%
EPS growth26.3%86.7%-5.3%
Profitability
Net margin12.3%17.8%11.8%
ROE41.6%35.8%8.4%
Balance sheet & cash
Debt / equity2.44x1.08x0.75x
Free cash flow yield15.4%3.8%11.2%
Dividend yield4.5%3.5%6.6%
Verdict
Investment ratingFavorable· 60Favorable· 66Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBMYtoday $64GSKtoday $53PFEtoday $26
2027$61.07 – $89.57+39% CAGR$73.96 – $108.47+105% CAGR$20.24 – $29.69+12% CAGR
2028$77.12 – $113.11+32% CAGR$138.10 – $202.55+96% CAGR$20.65 – $30.28+7% CAGR
2029$97.38 – $142.82+30% CAGR$257.88 – $378.23+93% CAGR$21.06 – $30.89+5% CAGR
2030$122.96 – $180.34+29% CAGR$481.54 – $706.26+91% CAGR$21.48 – $31.51+4% CAGR
2031$155.26 – $227.71+29% CAGR$899.18 – $1,318.80+90% CAGR$21.91 – $32.14+4% CAGR
5-yr CAGR19.2% – 28.7%76.3% – 90.3%-3.7% – 4.0%